WJCD  Vol.8 No.6 , June 2018
Hypertension in Clinical Practice: Control Rate in Short Term and Associated Factors in the Cardiology Department of the University Hospital Gabriel Touré (UH-GT) in Bamako (Mali)
Introduction: Hypertension (HTN) is for many decades a worldwide major risk factor for cardiovascular disease.However, hypertension control rates are globally low in the world. Studies on observance have been published in Mali but there is to our knowledge no published data about HTN control rate. We therefore conducted this study to assess the control rate in short term after 3 months management and to look for factors associated with HTN control. Materials and Methods: This study designed as prospective was conducted in the cardiology department of the University Hospital Gabriel Touré (UH-GT) from March 24 to September 24, 2017. All outpatients aged 18 years and more who came for visit and with hypertension as diagnose were involved. All patients have consented to participate in the study. Sociodemographic and data on physical examination including measures for BP, height, weight, waist circumference (WC) and direct costs as reported by the patients were recorded. Patients were asked about medication discontinuation and if yes why and then they were informed about the need to take regularly medication. The concept of chronic disease was explained to them. A formulary served to collect data that were inserted into a Microsoft Access database and analyzed using SPSS version 18. After describing of sociodemographics and continuous variables, crosstabs and finally a logistic regression was performed to look for blood pressure control predictors. Results: There was no statistical difference in sociodemographics between older and newly diagnosed patients. At 3 months globally 40.90% (31.1 for old Patients and 09.8% for newPatients) of the sample were controlled (Figure 1). For old patients, hypertension control rate at inclusion was 12.78% and reached 49.44% at 3 months (Figure 2). After logistic regression only HTN duration was significant predictor with Odd-ratio of 0.365 [0.213 - 0.624] 95% CI and p-value < 0.001 (old patients as reference). During the study period therapeutic regimen remained unchanged in 73.1% (44.4 for old Patients and 28.7 for newPatients. Calcium channel blocker (CCB), diuretics (DIU) and ACE-inhibitors (ACE-I) were the most prescribed drugs without statistical difference between patients with and without blood pressure under control. Conclusion: Short term hypertension control rate is low and patient follow-up must incorporate information at each visit as well as information through others channels for preventing hypertension. The duration of hypertension was found to be predictor for hypertension control.
Cite this paper
Bâ, H. , Menta, I. , Sangare, I. , Camara, Y. , Sidibe, N. , Coulibaly, S. , Traoré, D. , Dakouo, R. , Samaké, S. , Traoré, A. , Sidibé, S. , Cissouma, M. , Fofana, C. , Sidibe, L. and Sanogo, K. (2018) Hypertension in Clinical Practice: Control Rate in Short Term and Associated Factors in the Cardiology Department of the University Hospital Gabriel Touré (UH-GT) in Bamako (Mali). World Journal of Cardiovascular Diseases, 8, 288-297. doi: 10.4236/wjcd.2018.86028.
[1]   Wolrd Health Organization. A Global Brief on Hypertension.

[2]   Kearney, P.M., et al. (2005) Global Burden of Hypertension: Analysis of Worldwide Data. Lancet, 365, 217-223.

[3]   Roth, G.A., Huffman, M.D., Moran, A.E., Feigin, V., Mensah, G.A., Naghavi, M. and Murray, C.J.L. (2015) Global and Regional Patterns in Cardiovascular Mortality from 1990 to 2013. Circulation, 132, 1667-1678.

[4]   Joffres, M., Falaschetti, E., Gillespie, C., et al. (2013) Hypertension Prevalence, Awareness, Treatment and Control in National Surveys from England, the USA and Canada, and Correlation with Stroke and Ischemic Heart Disease Mortality: A cross-Sectional Study. BMJ, 3, e003423.

[5]   Ma, J. and Stafford, R.S. (2008) Screening, Treatment, and Control of Hypertension in US Private Physician Offices, 2003-2004. Hypertension, 51, 1275-1281.

[6]   Houlihan, S.J., Simpson, S.H., Cave, A.J., et al. (2009) Hypertension Treatment and Control Rates: Chart Review in an Academic Family Medicine Clinic. Canadian Family Physician, 55, 735-741.

[7]   McAlister, F.A., Wilkins, K., Joffres, M., et al. (2011) Changes in the Rates of Awareness, Treatment and Control of Hypertension in Canada over the Past Two Decades. CMAJ?: Canadian Medical Association Journal, 183, 1007-1013.

[8]   Gupta, R., et al. (2017) 25 Years Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rate in an Indian Urban Population: Jaipur Heart Watch. Indian Heart Journal.

[9]   Roy, A., Praveen, P.A., Amarch, R., et al. (2017) Changes in Hypertension Prevalence, Awareness, Treatment and Control Rates over 20 Years in National Capital Region of India: Results from a Repeat Cross-Sectional Study. BMJ, 7, e015639.

[10]   Ikeda, N., Sapienza, D., Guerrero, R., et al. (2014) Control of Hypertension with Medication: A Comparative Analysis of National Surveys in 20 Countries. Bulletin of the World Health Organization, 92, 10-19C.

[11]   Muntner, P., Gu, D.F., Wu, X.Q., Duan, X.F., Gan, W.Q., Whelton, P.K. and He, J. for the InterASIA Collaborative Group (2004) Factors Associated with Hypertension Awareness, Treatment, and Control in a Representative Sample of the Chinese Population. Hypertension, 43, 578-585.

[12]   He, J., Muntner, P., Chen, J., Roccella, E.J., Streiffer, R.H. and Whelton, P.K. (2002) Factors Associated with Hypertension Control in the General Population of the United States. Archives of Internal Medicine, 162, 1051-1058.

[13]   Esteghamati, A., Abbasi, M., Alikhani, S., Gouya, M.M., Delavari, A., Shishehbor, M.H., Forouzanfar, M., Hodjatzadeh, A. and Ramezani, R.D. (2008) Prevalence, Awareness, Treatment, and Risk Factors Associated with Hypertension in the Iranian Population: The National Survey of Risk Factors for Noncommunicable Diseases of Iran. American Journal of Hypertension, 21, 620-626.

[14]   Amelor, S., Kweku, M., Agboli, E., et al. (2016) Risk Factors Associated with Hypertension among Adults in the Hohoe Municipality, Ghana. BJMMR, 18, 1-12.

[15]   Gebreselassie, K.Z. and Padyab, M. (2015) Epidemiology of Hypertension Stages in Two Countries in Sub-Sahara Africa: Factors Associated with Hypertension Stages. International Journal of Hypertension, 2015, Article ID: 959256.

[16]   Yin, M. et al. (2016) Geographic Distributions in Hypertension Diagnosis, Measurement, Prevalence, Awareness, Treatment and Control Rates among Middle-Aged and Older Adults in China. Scientific Reports, 6, 37020.

[17]   Nayu, I., et al. (2014) Control of Hypertension with Medication: A Comparative Analysis of National Surveys in 20 Countries. Bulletin of the World Health Organization, 92, 10-19C.

[18]   Matsumura, K., Arima, H., Tominaga, M., Ohtsubo, T., Sasaguri, T., Fujii, K., Fukuhara, M., Uezono, K., Morinaga, Y., Ohta, Y., Otonari, T., Kawasaki, J., Kato, I., Tsuchihashi, T., The Comfort Investigators (2013) Impact of Antihypertensive Medication Adherence on Blood Pressure Control in Hypertension: The COMFORT Study. QJM: An International Journal of Medicine, 106, 909-914.

[19]   Bakris, G., Sarafidis, P., Agarwal, R. and Ruilope, L. (2014) Review of Blood Pressure Control Rates and Outcomes. Journal of the American Society of Hypertension, 8, 127-141.

[20]   Gharaibeh, K.A., Turner, S.T., Hamadah, A.M., Chapman, A.B., Cooper-Dehoff, R.M., Johnson, J.A., Gums, J.G., Bailey, K.R. and Schwartz, G.L. (2016) Comparison of Blood Pressure Control Rates among Recommended Drug Selection Strategies for Initial Therapy of Hypertension. American Journal of Hypertension, 29, 1186-1194.